Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants
Aging Clinical and Experimental Research · 22.05.2024 · 36 (1)
DOI: 10.1007/s40520-024-02768-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Clinical and Experimental Research, online erschienen am 22.05.2024. Verfasst von Théodore Decaix und 5 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics department, APHP Paris Cité University, Lariboisière-Fernand Widal Hospital, Paris, France. theodore.decaix@aphp.fr. Hauptthemen laut MEDLINE: Drug Interactions, Anticoagulants, Hospitalization. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Purpose
Polypharmacy is a frequent situation in older adults that increases the risk of drug-drug interactions (DDIs), both pharmacokinetic (PK) and pharmacodynamic (PD). Direct oral anticoagulants (DOACs) are frequently prescribed in older adults, mainly because of the high prevalence of atrial fibrillation (AF). DOACs are subject to cytochrome P450 3A4 (CYP3A4)- and/or P-glycoprotein (P-gp)-mediated PK DDIs and PD DDIs when co-administered with drugs that interfere with platelet function. The aim of our study was to assess the prevalence of DDIs involving DOACs in older adults and the associated risk factors at admission and discharge.
Methods
This was a cross-sectional study conducted in an acute geriatric unit between January 1, 2018 and December 31, 2022, including patients over 75 years of age treated with DOACs at admission and/or discharge, for whom a comprehensive collection of co-medications was performed.
Results
From 909 hospitalizations collected, the prevalence of PK DDIs involving DOACs was 16.9% at admission and 20.7% at discharge, and the prevalence of PD DDIs was 20.7% at admission and 20.2% at discharge. Factors associated with DDIs were bleeding history [adjusted odds ratio (ORa) 1.74, 95% confidence interval (CI) 1.13–2.68], number of drugs > 6 (ORa 2.54, 95% CI 1.88–3.46) and reduced dose of DOACs (ORa 0.39, 95% CI 0.28–0.54) at admission and age > 87 years (ORa 0.74, 95% CI 0.55–0.99), number of drugs > 6 (ORa 2.01, 95% CI 1.48–2.72) and reduced dose of DOACs (ORa 0.41, 95% CI 0.30–0.57) at discharge.
Conclusion
This study provides an indication of the prevalence of DDIs as well as the profile of DDIs and patients treated with DOACs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geriatrics department, APHP Paris Cité University, Lariboisière-Fernand Widal Hospital, Paris, France. theodore.decaix@aphp.fr.
- Paris-Cité University, CNRS, Paris, F-75006, CitCoM, France. theodore.decaix@aphp.fr.
- Faculty of Pharmacy, Paris-Cité University, 4 avenue de l'Observatoire, Paris, 75006, France. theodore.decaix@aphp.fr.
- Acute Geriatrics Unit, Charles Foix Hospital, APHP Sorbonne University, Ivry-sur-Seine, France.
- Paris-Cité University, CNRS, Paris, F-75006, CitCoM, France.
- Department of biology, National Hospital Center Of ophthalmology, 15-20, F-75012, Paris, France.
Zitieren
APA
Decaix, T., Kemache, K., Gay, P., Ketz, F., Laprévote, O., & Pautas, É. (2024). Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants. Aging Clinical and Experimental Research, 36(1). https://doi.org/10.1007/s40520-024-02768-w
Vancouver
Decaix T, Kemache K, Gay P, Ketz F, Laprévote O, Pautas É. Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants. Aging Clinical and Experimental Research. 2024;36(1). doi:10.1007/s40520-024-02768-w
BibTeX
@article{Decaix2024,
author = {Decaix, Théodore and Kemache, Kenza and Gay, Pierre and Ketz, Flora and Laprévote, Olivier and Pautas, Éric},
title = {Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants},
journal = {Aging Clinical and Experimental Research},
year = {2024},
volume = {36},
number = {1},
doi = {10.1007/s40520-024-02768-w}
}
EUVIMED